Search for: "Allergan Plc" Results 1 - 20 of 40
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
21 Apr 2022, 3:26 pm by PP&S Team
CVS Health Corp. and CVS Pharmacy Inc. will pay the state $484 million, while Teva Pharmaceuticals Industries Ltd. will pay $195 million, Allergan PLC over $134 million, and Endo Health Solutions $65 million. [read post]
9 Mar 2022, 2:06 pm by Kevin LaCroix
.: $135 million; Allergan plc: $130 million; and GCI Liberty $110 million). [read post]
15 Feb 2022, 2:20 pm by Eugene Volokh
Defendants cite to In re Allergan PLC Securities Litigation (S.D.N.Y. 2020), where the court granted a portion of a motion to seal because the subject documents contained information about an algorithm that constituted a trade secret. [read post]
30 Jul 2021, 7:01 am by Simmons Hanly Conroy
The New York State opioid trial continues against three major drugmakers, Endo International Plc., Teva Pharmaceutical Industries Ltd., and AbbVie Inc’s Allergan unit, which all stand accused of having deceptively marketed their opioid painkillers. [read post]
19 Apr 2021, 8:01 am by Dan Bressler
” “Illinois-based AbbVie’s involvement in the case stems from its acquisition of Allergan PLC, which is facing more than 3,000 lawsuits alleging unlawful marketing and sales of prescription narcotics. [read post]
6 May 2020, 1:51 pm by Doyle, Barlow & Mazard PLLC
’s (“AbbVie”) $63 billion acquisition of Allergan plc (“Allergan”) on the condition that the merging parties divest three minor products. [read post]
19 Feb 2020, 1:03 pm by Doyle, Barlow & Mazard PLLC
Federal Trade Commission (“FTC”) raising concerns that the divestiture of Allergan plc’s (“Allergan”) pipeline drug, brazikumab, will not succeed unless the FTC addresses AbbVie’s use of rebate walls. [read post]
Harris is Associate Vice President and Country Manager for Allergan PLC in Brazil. [read post]
30 Sep 2019, 6:08 am by Deb Givens
Federal Trade Commission (FTC) has requested for more information from AbbVie Inc and botox maker Allergan Plc on their $63 billion deal, the companies said on Friday. [read post]
23 Sep 2019, 6:31 am by Deb Givens
’s $63 billion bid for troubled smaller rival Allergan Plc were among the largest deals announced this year. [read post]
30 Jan 2019, 5:06 am by Sara E. Teller
Besides Purdue Pharma LP, the list of defendants named in NYC’s suit includes long-time opioid manufacturers Allergan Plc, Endo International Plc, Johnson & Johnson, and Teva Pharmaceutical Industries Ltd., and distributors AmerisourceBergen Corp, Cardinal Health Inc and McKesson Corp. [read post]
3 Jul 2018, 7:12 am by James Yang
Allergan plc (NYSE:AGN) is a global pharmaceutical company. [read post]
5 Jun 2018, 8:04 am by Howard Bashman
“Judges Criticize Allergan’s Use of Mohawk Tribe’s Sovereignty”: Susan Decker of Bloomberg News has a report that begins, “Allergan Plc faced a skeptical appeals court Monday as the company defended its use of an American Indian tribe’s sovereign immunity to avoid challenges to its patents from generic-drug makers. [read post]
24 Feb 2018, 10:12 am by Lawrence B. Ebert
CSR PLC, 771 F.3d 1336, 1342 (Fed. [read post]
1 Dec 2017, 11:35 am by Nate Nead
Big pharma players such as Eli Lilly, Novo Nordisk and Allergan are committed to voluntary price restraints, while companies such as Novartis and Roche are in favor of value-based pricing. [read post]
16 Nov 2017, 6:17 am
Company Name Annual Director Retainer Regeneron Pharmaceuticals $2,074,085 Tesla $1,664,928 The Goldman Sachs Group $575,000 Salesforce.com $550,000 Celgene Corporation $524,871 Reynolds American $496,480 Valeant Pharmaceuticals International $475,000 Allergan PLC $450,000 Everest Re Group, Ltd. $447,030 Oracle $429,172 (more…) [read post]
26 Sep 2017, 12:46 pm by Associated Press
., Janssen Pharmaceuticals Inc. and Allergan PLC, filed a brief Friday saying they’ve complied with the U.S. [read post]
4 Jan 2017, 8:26 am by Molly Crabtree
 It is well-known that the DOJ has been investigating generic drug companies for approximately two years, and as a result of the disclosure of those investigations, shareholder class action lawsuits began being filed in November 2016 against manufacturers Endo International, plc, Allergan plc and various predecessors and executives. [read post]